Eland to sell off EDT
Plans to sell Elan’s drug technology business EDT may rise a portion from when Kelly Martin aimed to sell in 2008.
Elan’s EDT is said to be worth $900m should it float on the US Stock market. Elan almost sold off for $1.4bn in 2008 with a number of equities reaching the second round of bidding.
Between the collapse of Lehman Brothers and financial panic, the deal was scuppered.
Here’s hoping the deal goes their way this time around!
